In CNS diseases, several autoantibodies linked to paraneoplastic neurological syndromes (PNS) have been identified, such as the anti-HuD antibodies and anti-Yo antibodies in the 1980s [3,4,5,6]. The gene discussed is CDR2; the disease is paraneoplastic neurologic syndrome.